Magnetic Resonance Imaging of Prostate Adenocarcinoma: Detection and Staging.
Ward RD, Purysko AS.
Top Magn Reson Imaging. 2020 Feb;29(1):17-30. doi: 10.1097/RMR.0000000000000226.
Overview of prostate anatomy, histology, and pathology.
Lee CH, Akin-Olugbade O, Kirschenbaum A.
Endocrinol Metab Clin North Am. 2011 Sep;40(3):565-75, viii-ix. doi: 10.1016/j.ecl.2011.05.012.
Limited Adenocarcinoma of the Prostate on Needle Core Biopsy.
Bell PD, Teramoto Y, Gurung PMS, Yang Z, Miyamoto H.
Arch Pathol Lab Med. 2022 Apr 1;146(4):469-477. doi: 10.5858/arpa.2020-0835-OA.
Cribriform Pattern of The Prostate Adenocarcinoma: Sensitivity of Multiparametric MRI.
Tuna MB, Arslan A, Kök YB, Doganca T, Argun OB, Tufek I, Pirdal BZ, Saglican Y, Obek C, Karaarslan E, Kural AR.
Urol J. 2022 Dec 25;20(1):34-40. doi: 10.22037/uj.v19i.7382.
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.
Berglund E, Maaskola J, Schultz N, Friedrich S, Marklund M, Bergenstråhle J, Tarish F, Tanoglidi A, Vickovic S, Larsson L, Salmén F, Ogris C, Wallenborg K, Lagergren J, Ståhl P, Sonnhammer E, Helleday T, Lundeberg J.
Nat Commun. 2018 Jun 20;9(1):2419. doi: 10.1038/s41467-018-04724-5.
Is Grade Group 1 (Gleason score 3 + 3 = 6) adenocarcinoma of the prostate really cancer?
Epstein JI.
Curr Opin Urol. 2022 Jan 1;32(1):91-95. doi: 10.1097/MOU.0000000000000945.
More Than Detection of Adenocarcinoma - Indications and Findings in Prostate MRI in Benign Prostatic Disorders.
Oerther B, Sigle A, Franiel T, Teichgräber U, Bamberg F, Gratzke C, Benndorf M.
Rofo. 2022 May;194(5):481-490. doi: 10.1055/a-1719-1463. Epub 2022 Jan 26.
Ductal adenocarcinoma of the prostate with oncocytic morphology.
Punjabi LS, Ng CK, Cheng L, Tan PH.
Pathology. 2024 Apr;56(3):415-419. doi: 10.1016/j.pathol.2023.06.014. Epub 2023 Sep 1.
Association of high-grade prostatic intraepithelial neoplasia immunohistochemical profile with acinar adenocarcinoma of the prostate.
Dantés-Durán MA, Castelán-Maldonado EE, Palacios-Saucedo GDC.
Gac Med Mex. 2023;159(2):91-95. doi: 10.24875/GMM.M22000752.
Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma.
Bisegna C, Gravina GL, Pierconti F, Martini M, Larocca L, Rossi P, Grimaldi P, Dolci S, Di Stasi S, Jannini EA.
Andrology. 2020 Mar;8(2):427-433. doi: 10.1111/andr.12695. Epub 2019 Aug 21.
